Methotrexate Reduces Pain in Inflammatory Hand Osteoarthritis
1. Methotrexate 20 mg once weekly resulted in significant pain reduction among patients with hand...
Read MoreDec 6, 2023
1. Methotrexate 20 mg once weekly resulted in significant pain reduction among patients with hand...
Read MoreDec 6, 2023
1. In this case-control study, those with tongue cancer were found to have ten-fold increases in...
Read MoreDec 5, 2023
1. In this randomized controlled trial, the minimum stent area following percutaneous coronary...
Read MoreDec 5, 2023
1. Patients randomized to have Zinc (Zn) supplementation incorporated into an 8-week diet and...
Read MoreDec 1, 2023
1. In this prospective study, ADHD symptoms were associated with an increased risk of...
Read MoreNov 30, 2023
1. Docosahexaenoic acid supplementation at the in utero dose for infants born at less than 29...
Read MoreNov 30, 2023
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups....
Read MoreNov 29, 2023
1. Colchicine did not significantly reduce the risk of atrial fibrillation or myocardial injury...
Read MoreNov 28, 2023
1. The median overall survival was 12.1 months in the erdafitinib group and 7.8 months in the...
Read MoreNov 28, 2023
1. Overall pathologic complete response to treatment of triple-negative breast cancer with a...
Read MoreNov 25, 2023
1. In this observational study, patients in high remote patient monitoring (RPM) practices had...
Read MoreNov 25, 2023
1. In this randomized noninferiority trial, pulsed-field ablation was noninferior to thermal...
Read MoreNov 25, 2023
1. This randomised control trial demonstrated that a standardised and manualised intervention in...
Read MoreNov 24, 2023
1. This randomized pilot study demonstrates that fasting blood glucose (FBG), systolic blood...
Read MoreNov 24, 2023
1. In this randomized controlled trial of patients with patellofemoral pain (PFP), home-based...
Read MoreNov 23, 2023
1. In this randomized controlled trial, botulinum toxin was more effective than placebo in...
Read MoreNov 22, 2023
1. In this randomized controlled trial, in non-alcohol fatty liver disease (NAFLD) patients who...
Read MoreNov 21, 2023
1. Progression-free survival was not reached in the selpercatinib group and was 16.8 months in the...
Read MoreNov 19, 2023
1. For patients with unfavorable nonmetastatic prostate cancer aged above 70 years, PSA levels...
Read MoreNov 19, 2023
1. In this cohort study, a 38% increased risk of stroke was reported amongst black women reporting...
Read More